Skip to main content
Springer logoLink to Springer
. 2018 Oct 2;13(5):667. doi: 10.1007/s11523-018-0598-6

Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease

Maximilian Hochmair 1,
PMCID: PMC6828467  PMID: 30280283

Correction to: Targeted Oncology (2018) 13:269–285

10.1007/s11523-018-0566-1

Enhanced digital features were retrospectively added to this article.

To view enhanced digital features for this article go to 10.6084/m9.figshare.7094075.

Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Footnotes

The online version of the original article can be found at 10.1007/s11523-018-0566-1


Articles from Targeted Oncology are provided here courtesy of Springer

RESOURCES